Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers

Abstract Sideroflexin (SFXN) family genes encode for a group of mitochondrial proteins involved in cellular processes such as iron homeostasis, amino acid metabolism, and energy production. Recent studies showed that they were aberrantly expressed in certain human cancers. However, there is a paucit...

Full description

Saved in:
Bibliographic Details
Main Authors: Hua Huang, Huibo Lian, Wang Liu, Benyi Li, Runzhi Zhu, Haiyan Shao
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Human Genomics
Subjects:
Online Access:https://doi.org/10.1186/s40246-024-00705-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861777772838912
author Hua Huang
Huibo Lian
Wang Liu
Benyi Li
Runzhi Zhu
Haiyan Shao
author_facet Hua Huang
Huibo Lian
Wang Liu
Benyi Li
Runzhi Zhu
Haiyan Shao
author_sort Hua Huang
collection DOAJ
description Abstract Sideroflexin (SFXN) family genes encode for a group of mitochondrial proteins involved in cellular processes such as iron homeostasis, amino acid metabolism, and energy production. Recent studies showed that they were aberrantly expressed in certain human cancers. However, there is a paucity of information about their expression in prostate cancer. In this study, we took a comprehensive approach to investigate their expression profiles in benign prostate tissue, prostate-derived cell lines, and prostate cancer tissues using multiple transcriptome datasets. Our results showed that SFXN1/3/4 genes were predominantly expressed in prostate tissue and cell lines. SFXN2/4 genes were significantly upregulated while the SFXN3 expression was significantly downregulated in malignant tissues compared to benign tissues. SFXN4 expression was identified as a diagnostic biomarker and prognostic factor for unfavorite survival outcomes. In advanced prostate cancers, SFXN2/4 expressions were positively correlated with the androgen receptor signaling activity but negatively correlated with the neuroendocrinal features. Further analysis discovered that SFXN5 expression was significantly elevated in neuroendocrinal prostate cancers. In conclusion, SFXN2/4 expressions are novel biomarkers in prostate cancer diagnosis and prognosis.
format Article
id doaj-art-08b75fa946ec41e1aa0af0f625c2c30c
institution Kabale University
issn 1479-7364
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Human Genomics
spelling doaj-art-08b75fa946ec41e1aa0af0f625c2c30c2025-02-09T12:46:35ZengBMCHuman Genomics1479-73642025-02-0119111310.1186/s40246-024-00705-6Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancersHua Huang0Huibo Lian1Wang Liu2Benyi Li3Runzhi Zhu4Haiyan Shao5Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital, The Affiliated People’s Hospital, Hangzhou Medical CollegeUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital, The Affiliated People’s Hospital, Hangzhou Medical CollegeDepartment of Urology, The University of Kansas Medical CenterDepartment of Urology, The University of Kansas Medical CenterThe Children’s Hospital, Zhejiang University School of MedicineUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital, The Affiliated People’s Hospital, Hangzhou Medical CollegeAbstract Sideroflexin (SFXN) family genes encode for a group of mitochondrial proteins involved in cellular processes such as iron homeostasis, amino acid metabolism, and energy production. Recent studies showed that they were aberrantly expressed in certain human cancers. However, there is a paucity of information about their expression in prostate cancer. In this study, we took a comprehensive approach to investigate their expression profiles in benign prostate tissue, prostate-derived cell lines, and prostate cancer tissues using multiple transcriptome datasets. Our results showed that SFXN1/3/4 genes were predominantly expressed in prostate tissue and cell lines. SFXN2/4 genes were significantly upregulated while the SFXN3 expression was significantly downregulated in malignant tissues compared to benign tissues. SFXN4 expression was identified as a diagnostic biomarker and prognostic factor for unfavorite survival outcomes. In advanced prostate cancers, SFXN2/4 expressions were positively correlated with the androgen receptor signaling activity but negatively correlated with the neuroendocrinal features. Further analysis discovered that SFXN5 expression was significantly elevated in neuroendocrinal prostate cancers. In conclusion, SFXN2/4 expressions are novel biomarkers in prostate cancer diagnosis and prognosis.https://doi.org/10.1186/s40246-024-00705-6Prostate cancerSideroflexin family genesCastration-resistanceNeuroendocrinal progressionAndrogen receptor modulation
spellingShingle Hua Huang
Huibo Lian
Wang Liu
Benyi Li
Runzhi Zhu
Haiyan Shao
Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
Human Genomics
Prostate cancer
Sideroflexin family genes
Castration-resistance
Neuroendocrinal progression
Androgen receptor modulation
title Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
title_full Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
title_fullStr Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
title_full_unstemmed Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
title_short Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
title_sort sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
topic Prostate cancer
Sideroflexin family genes
Castration-resistance
Neuroendocrinal progression
Androgen receptor modulation
url https://doi.org/10.1186/s40246-024-00705-6
work_keys_str_mv AT huahuang sideroflexinfamilygenesweredysregulatedandassociatedwithtumorprogressioninprostatecancers
AT huibolian sideroflexinfamilygenesweredysregulatedandassociatedwithtumorprogressioninprostatecancers
AT wangliu sideroflexinfamilygenesweredysregulatedandassociatedwithtumorprogressioninprostatecancers
AT benyili sideroflexinfamilygenesweredysregulatedandassociatedwithtumorprogressioninprostatecancers
AT runzhizhu sideroflexinfamilygenesweredysregulatedandassociatedwithtumorprogressioninprostatecancers
AT haiyanshao sideroflexinfamilygenesweredysregulatedandassociatedwithtumorprogressioninprostatecancers